TRACEY BRYANT: Open Payments
NPI 1962473256 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 59 payments from 17 companies in 2025. Trend: 2023 $1,177 · 2024 $1,373 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $283 |
| ABBVIE INC. | 11 | $210 |
| PFIZER INC. | 12 | $149 |
| Novo Nordisk Inc | 9 | $147 |
| SANOFI PASTEUR INC. | 2 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| ALK-Abello, Inc | 2 | $32 |
| Viatris Specialty LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: QULIPTA, NURTEC ODT, FARXIGA, UBRELVY, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE, Ozempic, JARDIANCE, Rybelsus.
Industry payments across WA — which companies pay providers there.
